1. Home
  2. NRO vs VOR Comparison

NRO vs VOR Comparison

Compare NRO & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRO
  • VOR
  • Stock Information
  • Founded
  • NRO 2003
  • VOR 2015
  • Country
  • NRO United States
  • VOR United States
  • Employees
  • NRO N/A
  • VOR N/A
  • Industry
  • NRO Finance/Investors Services
  • VOR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRO Finance
  • VOR Health Care
  • Exchange
  • NRO Nasdaq
  • VOR Nasdaq
  • Market Cap
  • NRO 159.4M
  • VOR 134.8M
  • IPO Year
  • NRO N/A
  • VOR 2021
  • Fundamental
  • Price
  • NRO $3.28
  • VOR $0.82
  • Analyst Decision
  • NRO
  • VOR Strong Buy
  • Analyst Count
  • NRO 0
  • VOR 7
  • Target Price
  • NRO N/A
  • VOR $11.36
  • AVG Volume (30 Days)
  • NRO 239.4K
  • VOR 345.1K
  • Earning Date
  • NRO 01-01-0001
  • VOR 03-19-2025
  • Dividend Yield
  • NRO 11.41%
  • VOR N/A
  • EPS Growth
  • NRO N/A
  • VOR N/A
  • EPS
  • NRO N/A
  • VOR N/A
  • Revenue
  • NRO N/A
  • VOR N/A
  • Revenue This Year
  • NRO N/A
  • VOR N/A
  • Revenue Next Year
  • NRO N/A
  • VOR N/A
  • P/E Ratio
  • NRO N/A
  • VOR N/A
  • Revenue Growth
  • NRO N/A
  • VOR N/A
  • 52 Week Low
  • NRO $2.51
  • VOR $0.63
  • 52 Week High
  • NRO $3.45
  • VOR $2.43
  • Technical
  • Relative Strength Index (RSI)
  • NRO 41.60
  • VOR 28.59
  • Support Level
  • NRO $3.27
  • VOR $0.85
  • Resistance Level
  • NRO $3.35
  • VOR $0.93
  • Average True Range (ATR)
  • NRO 0.05
  • VOR 0.11
  • MACD
  • NRO -0.00
  • VOR -0.03
  • Stochastic Oscillator
  • NRO 6.25
  • VOR 0.82

About NRO Neuberger Berman Real Estate Securities Income Fund Inc.

NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Share on Social Networks: